In a 30-year-old patient with no known comorbidities who sustained polytrauma including a subarachnoid hemorrhage, is receiving mannitol, has a capillary blood glucose of 250 mg/dL, urine output of 250 mL per hour, serum sodium of 149 mmol/L, potassium of 5.5 mmol/L, and chloride of 124 mmol/L, what is the most likely cause of the hypernatremia?

Mannitol-Induced Hypernatremia with Hyperchloremic Metabolic Acidosis and Stress Hyperglycemia

The most likely cause of this patient's electrolyte abnormalities is mannitol-induced osmotic diuresis leading to hypernatremia (Na 149), hyperchloremia (Cl 124), and hyperkalemia (K 5.5), compounded by stress-induced hyperglycemia (CBG 250 mg/dL) from polytrauma.

Primary Mechanism: Mannitol-Induced Electrolyte Disturbances

The clinical picture is dominated by mannitol's effects. Mannitol causes obligatory osmotic diuresis with excessive water loss exceeding electrolyte loss, directly causing hypernatremia 1. The FDA label explicitly warns that "with continued administration of mannitol, loss of water in excess of electrolytes can cause hypernatremia" and that "the obligatory diuretic response following rapid infusion of 25% mannitol may further aggravate pre-existing hemoconcentration" 1.

Key Pathophysiologic Points:

• High urine output (250 mL/hr): This confirms active osmotic diuresis from mannitol
• Hypernatremia (149 mmol/L): Results from free water loss exceeding sodium loss during mannitol diuresis 1
• Hyperchloremia (124 mmol/L): Likely represents hyperchloremic metabolic acidosis from volume contraction and relative chloride retention
• Hyperkalemia (5.5 mmol/L): May reflect transcellular shifts from acidosis, cellular injury from trauma, or impending renal dysfunction

Contributing Factor: Stress Hyperglycemia

The elevated glucose (250 mg/dL) represents stress-induced hyperglycemia from polytrauma. Sustained moderate hyperglycemia within the first 48 hours after polytrauma is independently associated with poor functional outcomes 2. This is not diabetes insipidus, as DI would present with hypotonic polyuria and typically lower serum sodium initially.

Critical Distinction from Other Causes

This is NOT cerebral salt wasting or SIADH, which cause hyponatremia, not hypernatremia 3. While these conditions are common in SAH patients (occurring in up to 50% of neurosurgical patients), they present with low sodium 3. The hypernatremia here points directly to mannitol as the culprit.

Immediate Clinical Concerns

Renal Function Monitoring

The FDA mandates close monitoring as "renal complications, including irreversible renal failure have been reported in patients receiving mannitol" 1. The combination of high urine output with rising potassium raises concern for evolving acute kidney injury. If urine output declines during mannitol infusion, the infusion must be suspended 1.

Risk of Poor Outcomes

Hypernatremia after SAH is independently associated with poor outcomes (OR 2.7,95% CI 1.2-6.1) 4. A positive correlation exists between highest sodium values and worse Glasgow Outcome Scale scores at 3 months 4. More recent data confirms that hypernatremia carries higher inpatient mortality and worse overall outcomes compared to hyponatremia or normonatremia in SAH patients 5.

Management Algorithm

1. Immediately check: Serum osmolality, calculated osmolar gap, BUN/creatinine, arterial blood gas

   • Osmolar gap will be elevated if significant mannitol accumulation
   • ABG will clarify acid-base status (likely metabolic acidosis from hyperchloremia)

2. Reduce or hold mannitol: Given Na 149 and high urine output, consider alternative ICP management

   • 3% hypertonic saline is equally effective for ICP control without the same diuretic effect 6

3. Fluid management: Replace free water deficit cautiously

   • Critical warning: Do not correct sodium faster than 10 mmol/L per day to avoid osmotic demyelination 3
   • Use hypotonic fluids (0.45% saline or D5W) to replace free water losses
   • Monitor hourly urine output and adjust replacement

4. Monitor electrolytes every 4-6 hours: Sodium, potassium, chloride, bicarbonate

   • The FDA specifically mandates that "serum sodium and potassium should be carefully monitored during mannitol administration" 1

5. Address hyperkalemia if worsening: Check ECG, consider treatment if K >5.5 or ECG changes present

6. Glucose control: Target glucose <180 mg/dL given association with poor outcomes in polytrauma 2

Critical Pitfall to Avoid

Do not aggressively fluid restrict thinking this is SIADH—this patient has the opposite problem (excessive free water loss from mannitol). Fluid restriction would worsen hypernatremia and potentially precipitate hypovolemic shock. The high urine output with rising sodium definitively excludes SIADH 3.